DOJ drops appeal of Plan B contraceptive ruling

[JURIST] The US Department of Justice and the Food and Drug Administration (FDA) [official websites] announced Monday that neither agency will seek to continue the appeal of a ruling [opinion, PDF] that allows women of all ages to access emergency contraception without a prescription. The US Court of Appeals for the Second Circuit [official website] refused to stay the ruling [JURIST report] last Wednesday. Judge Edward Korman of the US District Court for the Eastern District of New York [official website] ruled [JURIST report] in April that requiring a prescription for women under 16 to obtain the drug commonly known as Plan B [JURIST news archive] was a politically-motivated decision that resulted in arbitrary and capricious action by the FDA. The DOJ initially said it would appeal the decision [JURIST report], arguing the judge overstepped his authority. The FDA announced [press release] after the district court decision that it would comply with over-the-counter sales, but still require proof of age for some forms of the pill.

The decision to drop the appeal comes just weeks after the Obama administration urged [JURIST report] the appeals court to delay implementation of the ruling. After the initial complaint filed by women's rights groups, the Secretary of the Department of Health and Human Services (HHS) [official website], Kathleen Sebelius [HHS profile], intervened to block the ruling as it related to minors, citing inadequate evidence concerning adverse health effects.

 

About Paper Chase

Paper Chase is JURIST's real-time legal news service, powered by a team of 30 law student reporters and editors led by law professor Bernard Hibbitts at the University of Pittsburgh School of Law. As an educational service, Paper Chase is dedicated to presenting important legal news and materials rapidly, objectively and intelligibly in an accessible format.

© Copyright JURIST Legal News and Research Services, Inc., 2013.